Localized ultrasound enhances delivery of rapamycin from microbubbles to prevent smooth muscle proliferation.

[1]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[2]  G. Unger,et al.  Tacrolimus-eluting carbon-coated stents versus sirolimus-eluting stents for prevention of symptom-driven clinical end points , 2010, Clinical Research in Cardiology.

[3]  Richard Manasseh,et al.  Cavitation microstreaming and stress fields created by microbubbles. , 2010, Ultrasonics.

[4]  Zhigang Wang,et al.  Antitumor Effect of Docetaxel‐Loaded Lipid Microbubbles Combined With Ultrasound‐Targeted Microbubble Activation on VX2 Rabbit Liver Tumors , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  K. Ley,et al.  Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[6]  J. Hossack,et al.  Focused in vivo Delivery of Plasmid DNA to the Porcine Vascular Wall via Intravascular Ultrasound Destruction of Microbubbles , 2009, Journal of Vascular Research.

[7]  J. Hossack,et al.  Intravascular ultrasound detection and delivery of molecularly targeted microbubbles for gene delivery , 2009, 2009 IEEE International Ultrasonics Symposium.

[8]  Raffi Karshafian,et al.  Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. , 2009, Ultrasound in medicine & biology.

[9]  Nico de Jong,et al.  Ultrasound and Microbubble-Targeted Delivery of Macromolecules Is Regulated by Induction of Endocytosis and Pore Formation , 2009, Circulation research.

[10]  A. Kastrati,et al.  Drug-Eluting Stents in Percutaneous Coronary Intervention , 2009, Drug safety.

[11]  Shelton D Caruthers,et al.  Intramural Delivery of Rapamycin With &agr;v&bgr;3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[12]  William Wijns,et al.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. , 2007, Circulation.

[13]  Mark Borden,et al.  Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. , 2007, Annual review of biomedical engineering.

[14]  David B Matchar,et al.  Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. , 2007, JAMA.

[15]  Katherine W Ferrara,et al.  Therapeutic effects of paclitaxel-containing ultrasound contrast agents. , 2006, Ultrasound in medicine & biology.

[16]  Jeffrey C Bamber,et al.  Physical parameters affecting ultrasound/microbubble-mediated gene delivery efficiency in vitro. , 2006, Ultrasound in medicine & biology.

[17]  Nico de Jong,et al.  Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Adnan Kastrati,et al.  Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. , 2006, Journal of the American College of Cardiology.

[19]  Yan Ling Zhang,et al.  Development and Validation of a High-Throughput Assay for Quantification of the Proliferation Inhibitor ABT-578 Using LC/LC-MS/MS in Blood and Tissue Samples , 2005, Therapeutic drug monitoring.

[20]  R. Falotico,et al.  Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. , 2005, European journal of pharmacology.

[21]  Yun Zhou,et al.  Study of sonoporation dynamics affected by ultrasound duty cycle. , 2005, Ultrasound in medicine & biology.

[22]  Antonio Colombo,et al.  Novel site‐specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[23]  Raffi Bekeredjian,et al.  Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. , 2005, Journal of the American College of Cardiology.

[24]  Nico de Jong,et al.  Ultrasound-induced encapsulated microbubble phenomena. , 2004, Ultrasound in medicine & biology.

[25]  E. Unger,et al.  Therapeutic applications of lipid-coated microbubbles. , 2004, Advanced drug delivery reviews.

[26]  Cheri X Deng,et al.  Ultrasound-induced cell membrane porosity. , 2004, Ultrasound in medicine & biology.

[27]  Sanjiv Kaul,et al.  Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. , 2003, Ultrasound in medicine & biology.

[28]  Douglas L. Miller,et al.  DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro. , 2003, Ultrasound in medicine & biology.

[29]  Paul A Dayton,et al.  The magnitude of radiation force on ultrasound contrast agents. , 2002, The Journal of the Acoustical Society of America.

[30]  S. Rajagopalan,et al.  Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  Junru Wu,et al.  Reparable sonoporation generated by microstreaming. , 2002, The Journal of the Acoustical Society of America.

[32]  A. Klibanov,et al.  Detection of individual microbubbles of an ultrasound contrast agent: fundamental and pulse inversion imaging. , 2002, Academic radiology.

[33]  E. Unger,et al.  Local drug and gene delivery through microbubbles. , 2001, Progress in cardiovascular diseases.

[34]  S. Yalkowsky,et al.  Solubilization of rapamycin. , 2001, International journal of pharmaceutics.

[35]  B D Kahan,et al.  Clinical Pharmacokinetics of Sirolimus , 2001, Clinical pharmacokinetics.

[36]  P. Dayton,et al.  Mechanisms of contrast agent destruction , 2001, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[37]  M. Manns,et al.  Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[38]  A Machraoui,et al.  Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. , 2000, Journal of the American College of Cardiology.

[39]  K. Morgan,et al.  Optimization of microbubble destruction , 1999, 1999 IEEE Ultrasonics Symposium. Proceedings. International Symposium (Cat. No.99CH37027).

[40]  S Marx,et al.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. , 1999, Circulation.

[41]  R. Schwartz,et al.  Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. , 1998, The American journal of cardiology.

[42]  M. Leon,et al.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. , 1998, Journal of the American College of Cardiology.

[43]  S. Marx,et al.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. , 1995, Circulation research.

[44]  William Wijns,et al.  A Cause for Concern , 2007 .